ASP Isotopes Inc. (ASPI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1101 PENNSYLVANIA AVENUE NW WASHINGTON, DC 20004 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 289 - Miscellaneous Chemical Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 2,389 | ||||
| Cash and cash equivalents | 2,389 | ||||
| Receivables | |||||
| Other undisclosed current assets | 10,510 | 913 | |||
| Total current assets: | 10,510 | 3,302 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | 1,259 | 854 | |||
| Property, plant and equipment | 10,713 | 8,201 | |||
| Intangible assets, net (including goodwill) | 3,267 | ||||
| Goodwill | 3,267 | ||||
| Other noncurrent assets | 1,793 | 140 | |||
| Total noncurrent assets: | 17,032 | 9,194 | |||
| TOTAL ASSETS: | 27,542 | 12,496 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,423 | 1,716 | |||
| Accounts payable | 1,112 | 1,355 | |||
| Accrued liabilities | 1,311 | 361 | |||
| Deferred revenue | |||||
| Debt | 532 | 34 | |||
| Other liabilities | 1,500 | ||||
| Other undisclosed current liabilities | 1,219 | 186 | |||
| Total current liabilities: | 5,674 | 1,936 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 207 | ||||
| Long-term debt, excluding current maturities | |||||
| Finance lease, liability | 207 | ||||
| Liabilities, other than long-term debt | 2,720 | 742 | |||
| Other liabilities | 1,653 | ||||
| Operating lease, liability | 1,067 | 742 | |||
| Other undisclosed noncurrent liabilities | 111 | ||||
| Total noncurrent liabilities: | 3,037 | 742 | |||
| Total liabilities: | 8,711 | 2,679 | |||
| Equity | |||||
| Equity, attributable to parent, including: | 16,296 | 9,817 | |||
| Common stock | 489 | 359 | |||
| Common stock held by subsidiary | (1,963) | (38) | |||
| Additional paid in capital | 40,567 | 16,756 | |||
| Accumulated other comprehensive income (loss) | (921) | 255 | |||
| Accumulated deficit | (23,839) | (7,553) | |||
| Other undisclosed equity, attributable to parent | 1,963 | 38 | |||
| Equity, attributable to noncontrolling interest | 2,535 | ||||
| Total equity: | 18,831 | 9,817 | |||
| TOTAL LIABILITIES AND EQUITY: | 27,542 | 12,496 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Revenues | 433 | |||
| Cost of revenue (Cost of Goods and Services Sold) | (294) | (6,800) | ||
| Gross profit: | 139 | (6,800) | ||
| Operating expenses | (16,181) | (5,099) | ||
| Other undisclosed operating income (loss) | 6,800 | |||
| Operating loss: | (16,042) | (5,099) | ||
| Nonoperating income (expense) | (258) | 154 | ||
| Investment income, nonoperating | 6,050 | 6,050 | ||
| Gain (loss), foreign currency transaction, before tax | 45 | |||
| Interest and debt expense | (119) | |||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||
| Loss from continuing operations before equity method investments, income taxes: | (16,419) | (4,945) | ||
| Other undisclosed income from continuing operations before income taxes | 119 | |||
| Loss from continuing operations before income taxes: | (16,300) | (4,945) | ||
| Income tax expense (benefit) | 6 | |||
| Other undisclosed income from continuing operations | ||||
| Loss from continuing operations: | (16,294) | (4,945) | ||
| Other undisclosed net income | ||||
| Net loss: | (16,294) | (4,945) | ||
| Net income attributable to noncontrolling interest | 8 | |||
| Other undisclosed net loss attributable to parent | (8) | |||
| Net loss available to common stockholders, diluted: | (16,294) | (4,945) | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Net loss: | (16,294) | (4,945) | ||
| Other comprehensive loss | (16,300) | (4,945) | ||
| Other undisclosed comprehensive loss | ||||
| Comprehensive loss: | (32,594) | (9,890) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 17,497 | |||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 5,181 | |||
| Comprehensive loss, net of tax, attributable to parent: | (15,097) | (4,709) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.